Summary of Purpose
This study uses the PharMetrics and MarketScan US health care insurance claims database to estimate relative risks for non-fatal venous thromboembolism (including cerebral venous sinus thrombosis), ischemic stroke, and acute myocardial infarction (heart attack), in current users of ORTHO EVRA (norelgestromin and ethinyl estradiol contraceptive patch) compared to current users of oral levonorgestrel-containing...Read More →
The following dates are available for this trial. Trial information last updated on 15 July 2016.
|1 Nov 2006||2 Aug 2007||1 Jun 2007||1 Jun 2007||1 Jul 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Retrospective
- Sampling: Probability Sample